Enter B and W: Two new meningococcal vaccine programmes launched

Shamez Ladhani; Mary Ramsay; Raymond Borrow; Andrew Riordan; John M. Watson; Andrew J. Pollard

doi:10.1136/archdischild-2015-308928

Enter B and W: Two new meningococcal vaccine programmes launched

Shamez Ladhani
, Mary Ramsay
, Raymond Borrow
, Andrew Riordan
, John M. Watson
, Andrew J. Pollard^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

88 Citations (Scopus)

Abstract

In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis.¹ An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.².

Original language	English
Pages (from-to)	91-95
Number of pages	5
Journal	Archives of Disease in Childhood
Volume	101
Issue number	1
DOIs	https://doi.org/10.1136/archdischild-2015-308928
Publication status	Published - Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/archdischild-2015-308928

Cite this

@article{9defddca811f4d4ba63f3ca8566325cc,

title = "Enter B and W: Two new meningococcal vaccine programmes launched",

abstract = "In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis.1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.2.",

author = "Shamez Ladhani and Mary Ramsay and Raymond Borrow and Andrew Riordan and Watson, \{John M.\} and Pollard, \{Andrew J.\}",

year = "2016",

month = jan,

doi = "10.1136/archdischild-2015-308928",

language = "English",

volume = "101",

pages = "91--95",

journal = "Archives of Disease in Childhood",

issn = "0003-9888",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Enter B and W

T2 - Two new meningococcal vaccine programmes launched

AU - Ladhani, Shamez

AU - Ramsay, Mary

AU - Borrow, Raymond

AU - Riordan, Andrew

AU - Watson, John M.

AU - Pollard, Andrew J.

PY - 2016/1

Y1 - 2016/1

N2 - In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis.1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.2.

AB - In 2015, the UK became the first country in the world to have a comprehensive routine meningococcal vaccine programme targeting all of the main capsular groups of N. meningitidis.1 An infant vaccine programme against meningococcal capsular group B Neisseria meningitidis (MenB) was launched from 1st September with an aim to reduce endemic MenB disease in early childhood. On 1st August 2015, an adolescent programme against groups A, C, W and Y meningococci (MenACWY) was rolled out to halt a growing outbreak of capsular group W disease (MenW) caused by a hypervirulent clone of N. meningitidis, in addition to maintaining control against MenC disease provided by the current adolescent programme.2.

UR - https://www.scopus.com/pages/publications/84951936609

U2 - 10.1136/archdischild-2015-308928

DO - 10.1136/archdischild-2015-308928

M3 - Review article

C2 - 26672098

AN - SCOPUS:84951936609

SN - 0003-9888

VL - 101

SP - 91

EP - 95

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

IS - 1

ER -

Enter B and W: Two new meningococcal vaccine programmes launched

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this